BST - Features & Specs.
BST - Features:

The BST intended use is approved for hospital, clinics and home care in Europe,
Canada, Brazil and Israel (FDA approval is pending).
The BST device is comprised of two basic elements: a computerized controlled single channeled bioelectrical stimulator and a pair of surface electrodes.
The BST transmits a low intensity bio-current (micro-current density 0.3mA r.m.s./cm2) 
The BST treatment is operated through the surface electrodes attached to the skin. Before treatment mode is operated, the surface electrodes are placed on the healthy skin near the wound. The electrode-skin interface has an hypoallergenic conductive layer, which enables the use of a single pair of electrodes for 1 to 7 days.
The BST treatment is used twice or three times a day, for 30 minutes each (according to the physician's recommendations). Only during these treatment sessions the patient connected to the device, enabling full flexibility and movement during the rest of the day.
 
Warning: use of electrodes not according to their labeled usage time may results in skin adverse effects, reduced efficacy and patient compliance.   
 
BST - Specifications: